A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

NCT07705607 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1104

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy
Macular Edema

Interventions

DRUG: MK-8748
DRUG: Aflibercept

Sponsor

Merck Sharp & Dohme LLC